(Q38442025)

English

Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study

scientific article published on September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ovarian carcinoma

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Hermann Brustmann

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

396-402

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Telomeres shorten during ageing of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

C-kit immunoreactivity in endometrial adenocarcinomas and its clinicopathologic significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

A genetically defined model for human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Telomerase in breast cancer: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.04.035

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38442025&oldid=2165755330"